Clincosm LogoSign in Get a demo

dry eye syndromes

Showing NaN - NaN of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Syndromes, Eye Diseases Trial in Memphis (OTX-DED, Controlled Insertion, Collagen Punctal Plug)

Not yet recruiting
  • Dry Eye Syndromes
  • Eye Diseases
  • Memphis, Tennessee
    Ocular Therapeutix
Apr 12, 2023

Dry Eye Syndromes, Dry Eye Trial in United States (RGN-259, Placebo)

Completed
  • Dry Eye Syndromes
  • Dry Eye
  • Phoenix, Arizona
  • +19 more
May 2, 2022

Dry Eye, Dry Eye Syndromes Trial in Memphis (Reproxalap Ophthalmic Solution (0.25%), Vehicle Opthalmic Solution)

Completed
  • Dry Eye
  • Dry Eye Syndromes
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Opthalmic Solution
  • Memphis, Tennessee
    University Clinical Health
Mar 28, 2022

Dry Eye, Dry Eye Syndromes Trial in United States (Vehicle Opthalmic Solution, PL9643 Opthalmic Solution)

Recruiting
  • Dry Eye
  • Dry Eye Syndromes
  • Vehicle Opthalmic Solution
  • PL9643 Opthalmic Solution
  • Newport Beach, California
  • +9 more
Jan 20, 2022

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121

Completed
Has Results
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • KPI-121 0.25% Ophthalmic Suspension
  • Vehicle of KPI-121 0.25% Ophthalmic Suspension
  • Phoenix, Arizona
  • +59 more
Jan 19, 2021

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121, Placebo)

Completed
Has Results
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • Artesia, California
  • +10 more
Jan 4, 2021

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121

Completed
Has Results
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • KPI-121 0.25% Ophthalmic Suspension
  • Vehicle of KPI-121 0.25% Ophthalmic Suspension
  • Birmingham, Alabama
  • +61 more
Dec 10, 2020

Dry Eye Syndromes Trial in Louisville, Memphis, Nashville (Intranasal Tear Neurostimulator)

Completed
Has Results
  • Dry Eye Syndromes
  • Intranasal Tear Neurostimulator
  • Louisville, Kentucky
  • +2 more
Jan 17, 2020

Dry Eye Syndromes Trial in United States (MIM-D3 Ophthalmic Solution, Vehicle)

Completed
  • Dry Eye Syndromes
  • Waterbury, Connecticut
  • +4 more
Aug 15, 2019

Dry Eye Syndromes Trial in United States (Refresh Optive® Gel Drops, REFRESH LIQUIGEL®)

Completed
Has Results
  • Dry Eye Syndromes
  • Refresh Optive® Gel Drops
  • REFRESH LIQUIGEL®
  • Petaluma, California
  • +9 more
Apr 9, 2019

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in Phoenix, Andover, Memphis (Intranasal Lacrimal Neurostimulator (Oculeve))

Completed
Has Results
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • Intranasal Lacrimal Neurostimulator (Oculeve)
  • Phoenix, Arizona
  • +2 more
Sep 27, 2017

Dry Eye Syndromes Trial in Andover, Memphis (Cyclosporine 0.05% Ophthalmic Emulsion)

Completed
Has Results
  • Dry Eye Syndromes
  • Cyclosporine 0.05% Ophthalmic Emulsion
  • Andover, Massachusetts
  • +1 more
May 25, 2017

Dry Eye Syndromes Trial in United States (CP-690,550, Cyclosporine, CP-690,550 Vehicle)

Completed
Has Results
  • Dry Eye Syndromes
  • Chandler, Arizona
  • +26 more
Feb 27, 2013

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (rebamipide 2% ophthalmic suspension, eye drops)

Completed
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • rebamipide 2% ophthalmic suspension
  • placebo eye drops
  • Waterbury, Connecticut
  • +4 more
Jan 9, 2012